Lynn J. Okamoto
Chief Business and Technology Officer
Lynn is Chief Business and Technology Officer at AESARA where she focuses on integrating evidence consulting with digital solutions to improve the accessibility and communication of information for decision-making.
With more than 27 years in the healthcare industry, Lynn has global experience in management and scientific research for health economics, outcomes research (HEOR), and observational studies, as well expertise in healthcare analytics. Lynn has a passion for developing strategies for accessing and using real-world data and, most recently, she was responsible for the leadership, operations and strategic direction of a global CRO late-phase group. In addition, she previously developed an HEOR consulting team and created a longitudinal patient claims repository that supported clients’ needs to demonstrate research outcomes across all healthcare settings.
Cox FM, Cobb P, Chua W, McLaughlin TP, Okamoto LJ. The Cost of Influenza Management in Emergency Department and Hospital Settings. American Journal of Managed Care. 2000;6:205-214.
Okamoto LJ. Case Study: Conducting a Pharmacoeconomic Evaluation in Pharmacoeconomics and Outcomes: Applications for Patient Care, Module 2. American College of Clinical Pharmacy. 1996.
Okamoto LJ, Noonan M, DeBoisblanc BP, Kellerman DJ. Fluticasone Propionate Improves Quality of Life in Patients with Asthma Requiring Oral Corticosteroids. Annals of Allergy, Asthma & Immunology. 1996;76:455-61.
Smith DH, Malone DC, Lawson KA, Okamoto LJ, Battista C, Saunders WB. A National Estimate of the Economic Costs of Asthma. Am J Resp Crit Care Med. 1997;156:787-793.